Matches 1 - 50 out of 108 1 2 3 >
Match Document Document Title
7635708 Methods and pharmaceutical compositions for inhibiting tumor cell growth  
The present invention is based on the finding that activation of PPARγ plays a key role in inducing growth arrest and differentiation of certain actively proliferating cells. We show that...
7582664 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics  
The invention relates to a compound of formula (I): Wherein R 1 , R 2 , R 2′ , R 3 , R 4 and R 5 are as defined herein. The invention also relates to the use of said compound in therapeutics.
7528133 Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation  
The present invention provides methods of preventing or reducing oxytocin-mediated action by using a thiazolidinedione, such as troglitazone, or thiazolidinedione-like compounds. These methods...
7498327 Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligands  
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
7459473 N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres  
This invention relates to novel N-linked sulfonamides of N-heterocyclic carboxylic acid and carboxylic acid isosteres, their preparation, and use for treating neurological disorders including...
7411064 1-Heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands  
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor
7388029 Compositions and methods for treating hair loss using non-naturally occurring prostaglandins  
A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss,...
7361687 Arylsulphonamide derivatives and methods of preparing  
The present invention relates to novel arylsulphonamide compounds, defined by formula I and the description, as well as their method of preparation and their therapeutic use
7348017 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin  
A dithiazole compound or a salt thereof is disclosed. The compound inhibits matrix metalloprotease (MMPs) activity and can be used in pharmaceutical and cosmetic compositions for the treatment of...
7259179 Kinase inhibitors  
A compound of the general formula: or pharmaceutically acceptable salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating protein kinase-associated...
7223780 Triazole-derivatives as blood clotting enzyme factor Xa inhibitors  
The present invention is directed to the compound of formula I which is useful for inhibiting the activity of blood clotting enzyme Factor Xa. The present invention is also directed to compositions...
7214701 Active substance combinations having insecticidal and acaricdal properties  
The invention relates to insecticidal mixtures for protecting plants against attack by pests comprising (a) compounds of the formula (I) in which W, X, Y, Z, A, B, D and G...
7192940 Ether compounds  
The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias,...
7129256 Antiparkinsonism drugs  
A compound represented by the formula: wherein A is thiazolyl or the like, X is a bond or the like, m is an integer of 0 to 4, Y is optionally substituted alkyl or the like, Z is a substituent...
7129257 Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma  
Pyrazolo[3,4-e]benzoxazoles and analogues thereof for lowering intraocular pressure and treating glaucoma are disclosed.
7105556 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method  
Compounds are provided which have the structure wherein Q is C or N, X 1 is C or N, and R 1 , R 2 , R 2a , R 2b , R 2c , R 3 , Y, A, m, n, X 2 , X 3 and X 4 are as defined herein, which...
7087621 Benzo- and azabenzodithiazole compounds  
The present invention provides compounds of formula I or a pharmaceutically acceptable salt, solvate, prodrug or isomer thereof and compounds of the formula or a...
6951878 Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases)  
The present invention provides novel compounds, novel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein...
6936624 Agents for preserving technical materials against insects  
The use of the compounds of the formula (I) as agents for preserving technical materials against insects.
6927215 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (I)  
The present invention relates to novel heterocyclic fluoroalkenyl thioethers of the formula (I) in which X represents hydrogen, halogen or alkyl, m represents integers from 2 to 10, n...
6841536 Prodrugs and conjugates of thiol- and selenol-containing compounds and methods of use thereof  
Disclosed is a prodrug of the formula: where A is a sulfur or a selenium, and R is derived from a mono- di- or oligo- saccharide. Also disclosed is a prodrug of the formula: where A is...
6838439 Heterocytes as inhibitors of leucocyte adhesion and as VLA-4 antagonists  
The present invention relates to compounds of the formula I which are inhibitors of the adhesion and migration of leucocytes and/or antagonists of the adhesion receptor VLA-4 which belongs to...
6803379 PHARMACOLOGICAL AGENTS AND METHODS OF TREATMENT THAT INACTIVATE PATHOGENIC PROKARYOTIC AND EUKARYOTIC CELLS AND VIRUSES BY ATTACKING HIGHLY CONSERVED DOMAINS IN STRUCTURAL METALLOPROTEIN AND METALLOENZYME TARGETS  
The invention relates to the treatment of viral, bacterial, parasitic, proliferative diseases, neurodegenerative diseases, inflammatory diseases, immunological diseases, transplanted organ...
6780881 Freeze-dried pantoprazole preparation and pantoprazole injection  
Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium...
6777405 Detection and treatment of duplex polynucleotide damage  
Duplex polynucleotides containing damage or errors are detected with hindered intercalating compounds which are capable of intercalating only in the presence of such damage or error. Conditions...
6743817 Substituted fused pyrroleimines and pyrazoleimines  
Disclosed are compounds of the formula and the pharmaceutically acceptable salts thereof wherein R, Ar, A, n, R 1 and R 2 are defined herein. These compounds are highly selective agonists,...
6689372 Microbicidal active substances  
The use of oxathiazolones of formula is described R 1 is phenyl unsubstituted or substituted by one or more C 1 -C 5 alkyl, hydroxyl, halogen substituents or by a 1,3,4-oxathiazol-2-one...
6669926 Hydrophilic light absorbing indole compounds for determination of physiological function in critically ill patients  
Highly hydrophilic indole and benzoindole derivatives that absorb and fluoresce in the visible region of light are disclosed. These compounds are useful for physiological and organ function...
6579893 Use of troglitazone and related compounds for the treatment of cancer  
The present invention is directed toward the use of the drug Troglitazone and related thiazolidinedione compounds in the treatment of the climacteric and cancer. This use is based on the novel...
6576632 Biaryl compounds useful as anticancer agents  
The present invention relates to compounds of formula I and to pharmaceutically acceptable salts, hydrates and prodrugs thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 10 , R 11 , b, m, n, p...
6537989 Azadioxacycloalkene derivatives, methods for the production thereof and their use as fungicides and pest control agents  
The present invention relates to azadioxacycloalkenes of the formula I in which the substituents R 1 to R 5 and X, the index n and the bridge member W have the following meanings: R 1 is C 1...
6531496 O-aryl dithiazole dioxides  
The invention relates to new O-aryldithiazole dioxides, to two processes for their preparation, and to their use as pesticides in crop protection and in the protection of materials.
6521650 Amines as pharmaceutical agents  
Novel gamma aminobutyric acids of formula (I) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders,...
6518289 1-substituted-1-aminomethyl-cycloalkane derivatives (&equals gabapentin analogues), their preparation and their use in the treatment of neurological disorders  
Novel amines of formulas (1), (1C), (1F), (1G) and (1H) or a pharmaceutical acceptable salt thereof wherein n is an integer of from 0 to 2; m is an integer of from 0 to 3; R is sulfonamide, amide,...
6451790 Azadioxacycloalkenes and their use for combating harmful fungi and animal pests  
Compounds of formula I wherein W is optionally substituted alkylene; Y is N or CR a ; R a is hydrogen, halogen or alkyl; R 1 n represents hydrogen or 1 to 4 substituents; R 2 is hydrogen,...
6410574 Fungicidal composition and method for using the same  
The present invention relates to a fungicidal composition obtained by mixing a 1,2,3-thiadiazole derivative of general formula (I) useful as a plant disease controller with at least one fungicide...
6384056 Heterocyclic thioesters or ketones for vision and memory disorders  
This invention relates to pharmaceutical compositions and methods for treating a vision disorder, improving vision, treating memory impairment, or enhancing memory performance using heterocyclic...
6358942 Phenyloxazolidinones having a c-c bond 4-8 membered heterocyclic rings  
A compound of Formula (I): or pharmaceutical acceptable salts thereof wherein X is NR 1 ; R 1 is H, C 1-6 alkyl optionally substituted with one or more OH, CN, or halo, or R 1 is —(CH 2 ) h...
6339101 N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders  
This invention relates to novel compositions and uses of a N-linked sulfonamide of an N-heterocylic carboxylic acid or isostere thereof for treating a vision disorder or improving vision or...
6335036 Granular pharmaceutical preparation of ebselen  
A granular pharmaceutical preparation prepared by granulating finely powdered Ebselen(2-phenyl-1,2-benzisoselenazol-3(2H)-one) using a hydrophilic polymer, and an aqueous suspension thereof. The...
6326387 Methods and compositions for stimulating neurite growth  
The present invention relates to methods and pharmaceutical compositions for stimulating the growth of neurites in nerve cells. The compositions comprise a neurotrophic amount of a compound which...
6316476 Heterocyclic compounds with antibacterial and antimycotic properties  
The invention is drawn to novel antibiotics, XENORXIDES of formula shown below, wherein R 1 , R 2 =hydrogen, substituted or unsubstituted alkyl, cycloalkyl, acyl, aryl, aralkyl, or heterocyclyl...
6313164 Dithiolin derivatives, their preparation and their therapeutic effect  
Compounds of the formula (I): ##STR1## wherein one of m and n is 0, and the other is 0, 1 or 2; k is 0 or 1 to 12; R 1 is hydrogen, a substituent which is an aryl or a heterocyclic, or an...
6291533 Dietary supplements for each specific blood type  
Dietary supplement compositions designed to be responsive to specific blood types, and thus most beneficial for people with specific antigenic blood types.
6288092 Triaryl compounds  
(4-oxy-3-(aryl)phenyl)pyridine compounds, in free or acid addition salt form, are useful as pharmaceuticals for treatment and prophylaxis of inflammation, particularly inflammatory or obstructive...
6225330 Selective NPY (Y5) antagonists (tricyclics)  
This invention is directed to tricyclic compounds which are selective antagonists for NPY (Y5) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective...
6207690 Troglitazone compounds for treating climacteric and cancer  
The present invention is directed toward the use of the drug Troglitazone and related thiazolidinedione compounds in the treatment of the climacteric and cancer. This use is based on the novel...
6200997 Heterocyclyl-substituted phenyl compounds, processes and intermediates for their preparation and their use for controlling harmful fungi and animal pests  
The present invention relates to heterocyclyl-substituted phenyl compounds of the formula I, ##STR1## where the substituents have the following meanings: Y is halogen, C 1 -C 4 -alkyl, C 1 -C...
6197799 Dithiazoldioxides and the use thereof as microbicides  
The invention relates to novel dithiazole dioxides, to processes for their preparation and to their use in crop protection and in the protection of materials.
6136829 Oxathiadiazole derivatives usful as iNOS inhibitors  
1,3-diazolino and 1,3-diazolidino heterocycle derivatives useful as nitric oxide synthase inhibitors.
Matches 1 - 50 out of 108 1 2 3 >